Your body moves cholesterol through your bloodstream every second of every day. The efficiency of that process, how quickly lipids get cleared, how LDL levels behave, whether triglycerides tend to run high, is shaped in part by a single gene: APOE.

APOE (Apolipoprotein E) is one of the most studied genes in human genetics. It codes for a protein that acts as a shuttle, binding to fat molecules and guiding them to the right receptors for processing. When this shuttle works well, lipids get cleared efficiently. When it doesn’t, cholesterol can linger in your blood longer than it should.

What makes APOE especially interesting is that it comes in three common variants, and the combination you carry may influence your cardiovascular risk profile in meaningful ways.

Two SNPs, three alleles

The APOE gene sits on chromosome 19. Two specific SNPs (single nucleotide polymorphisms) define which version of APOE you carry:

rs429358 (position 45411941): The variant that defines the APOE4 allele
rs7412 (position 45412079): The variant that defines the APOE2 allele

These two positions combine to create three possible alleles:

Allele	rs429358	rs7412	Frequency
APOE2 (E2)	T/T	C/T or C/C	~8% in Europeans
APOE3 (E3)	T/T	C/C	~77% globally
APOE4 (E4)	C/T or C/C	C/C	~14% globally

Since you inherit one copy from each parent, you carry two alleles. The most common combination is E3/E3. But roughly 25% of people carry at least one E4 or E2 allele, and that’s where things get interesting from a cardiovascular perspective.

APOE4: the variant that gets the most attention

The E4 allele, defined by the C variant at rs429358, is associated with less efficient lipid clearance. Research suggests that each copy of E4 may influence LDL cholesterol levels, ApoB concentrations, and overall lipid metabolism.

The data from large-scale genome-wide association studies is consistent: carriers of one E4 allele show roughly 3x the risk per allele for certain conditions compared to E3/E3 individuals. Two copies compound that effect significantly. The confidence level on rs429358 in peer-reviewed research sits at 0.97, making it one of the most well-established genetic associations in cardiovascular and neurological research.

But context matters enormously here. Carrying an E4 allele doesn’t determine your cardiovascular future. It means your genetic starting point may require more attention to the factors you can control: diet, exercise, lipid monitoring, and lifestyle choices. Research suggests that E4 carriers who maintain healthy lipid levels through diet and activity can substantially offset the genetic predisposition.

Related biomarkers worth tracking if you carry E4 include LDL cholesterol, total cholesterol, ApoB, and triglycerides. These are the metabolic signals most directly tied to APOE function.

APOE2: generally protective, with a caveat

On the other end of the spectrum sits the E2 allele, defined by the T variant at rs7412. Research suggests E2 is generally protective, associated with an effect size of roughly 0.6x (meaning a lower relative risk for certain conditions compared to the E3 baseline). The confidence score on this variant is 0.95.

E2 carriers tend to show more efficient cholesterol clearance. And for most people, carrying one or two copies of E2 is associated with favorable lipid profiles.

But there’s a catch. Roughly 5-10% of people who are homozygous E2/E2 (carrying two copies) may develop a condition called type III hyperlipoproteinemia, characterized by elevated triglycerides and unusual cholesterol particle distribution. It’s uncommon, and it typically requires additional environmental triggers like obesity or hypothyroidism. Still, it’s a reminder that “protective” doesn’t always mean “worry-free.”

APOE3: the common baseline

E3 is the most frequent allele worldwide, carried by about 77% of the population. It represents the baseline against which E2 and E4 effects are measured. If you carry E3/E3, your APOE gene is functioning in the most typical pattern for lipid metabolism.

That doesn’t mean your cardiovascular health is on autopilot. Dozens of other genetic variants, along with diet, activity level, sleep, stress, and environmental exposures, all contribute to your overall risk profile. APOE is one important piece of a much larger picture.

Why population context matters

APOE allele frequencies vary across populations. E4 is found at roughly 14% globally, but that number is higher in certain African populations and lower in some East Asian groups. E2 runs at about 8% in European populations.

This matters because genetic risk is always calculated relative to population-level data. A variant that shows a strong association in one population may behave differently in another, depending on the surrounding genetic landscape, dietary norms, and environmental factors. Good genetic analysis accounts for these differences rather than applying a single risk number to everyone.

What you can actually do with this information

Knowing your APOE status isn’t about receiving a verdict. It’s about gaining a starting point for smarter health decisions. Research suggests several practical approaches for people who want to optimize cardiovascular wellness based on their APOE profile:

For E4 carriers:

Regular lipid panel monitoring (LDL, ApoB, triglycerides, total cholesterol) may be especially valuable
Research suggests that dietary patterns lower in saturated fat may be particularly relevant for E4 carriers
Consistent aerobic exercise is associated with improved lipid clearance across all genotypes, but E4 carriers may see outsized benefit
Conversations with a healthcare provider about monitoring frequency can help personalize your approach

For E2 carriers:

Generally favorable lipid metabolism, but periodic monitoring remains important
E2/E2 homozygotes should be aware of type III hyperlipoproteinemia as a possibility, particularly if triglyceride levels trend upward
Maintaining a healthy weight may help keep the protective benefits of E2 working in your favor

For E3/E3 carriers:

Standard cardiovascular wellness guidelines apply
Don’t assume average genetic risk means average outcomes. Your lifestyle choices, other genetic variants, and biomarker trends all shape your individual picture

Seeing APOE in the context of your full genetic profile

APOE is one of 256 SNPs that SoDNAscan analyzes as part of your personalized health book. And that context is what makes individual SNP data truly useful. Your APOE status interacts with variants in coagulation genes, methylation pathways, inflammatory markers, and metabolic regulators.

A single SNP, even one as well-studied as rs429358, tells a partial story. Your raw DNA file contains hundreds of thousands of data points. SoDNAscan cross-references the most research-backed variants against your blood work results and wearable health data to build a picture that’s specific to you, not a population average.

Your genetics load the odds. Your choices play the hand.

The APOE Gene and Cardiovascular Health: What Your Variants May Tell You